Otoacoustic Emission Measurements in Patients with Fibromyalgia Syndrome

INTRODUCTION: We aimed to analyze the cochlear functions in patients with Fibromyalgia syndrome (FMS). METHODS: The study designed as a prospective casecontrol study. Twenty-eight female and two male patients diagnosed with FMS according to American College of Rheumatology (ACR) 2010 criteria were included in the study. The control group consisted of 31 healthy age, gender and body mass index (BMI) matched subjects. Participants' sociodemographic data (age, gender, height, weight) were recorded. Otoacoustic emission tests (AOETs); distortion products (DP) and transient emission (TE) values were evaluated in FMS and control groups. RESULTS: Our study group consisted of 28 females and 2 males at the age of 42.9 ± 10.6 years. The mean BMI was 30.1 ± 5 kg / m2 . Our control group consisted of 27 females and 4 males aged 38.3 ±15.1 years. The mean BMI was 29.4 ± 2.4 kg / m 2 . Both groups were similar in age, sex, and BMI.Lower results were observed in most of different frequencies at AOETs in our FMS group. The hearing assessments at frequencies between 250 and 8.000 Hz showed a significant difference between the two groups (high hearing frequencies in the FMS group) in audiometry. DISCUSSION and CONCLUSION: İn FMS patients, cochlea may be more affected at higher frequencies and it may cause cochlear, hair cell dysfunction in these patients.

Fibromiyalji Sendromlu Hastalarda Otoakustik Emisyon Ölçümleri

GİRİŞ ve AMAÇ: Fibromiyalji sendromlu (FMS) hastalarda koklear fonksiyonların analizini amaçladık. YÖNTEM ve GEREÇLER: Çalışma prospektif bir vaka kontrol çalışması olarak tasarlanmıştır. Çalışmaya Amerikan Koleji Romatoloji (ACR) 2010 kriterlerine göre FMS tanısı konan 24 kadın ve 2 erkek hasta alındı. Kontrol grubu 31 sağlıklı yaş, cinsiyet ve vücut kitle indeksi (VKI) eşleştirilmiş deneklerden oluşmaktadır. Katılımcıların sosyodemografik verileri (yaş, cinsiyet, boy, kilo) kaydedildi. Otoakustik emisyon testleri (AOETs); Distorsiyon ürünleri (DP) ve geçici emisyon (TE) değerleri FMS ve kontrol gruplarında değerlendirildi. BULGULAR: Çalışma grubumuz 28 kadın ve 2 erkek olup yaşları ortalama 42.9 ± 10.6 yıl idi. Ortalama VKI 30.1 ± 5 kg / m2 idi. Kontrol grubumuz 27 kadın ve 4 erkek olup ortalama yaş 38.3 ±15.1 yıl idi. VKİ ortalaması 29.4 ± 2.4 kg / m2 idi. Her iki grup yaş, cinsiyet ve VKİ ile benzerdi.FMS grubumuzdaki AOET'lerdeki farklı frekansların çoğunda düşük sonuçlar gözlendi. İşitme değerlendirmesi 250 ve 8.000 Hz arasındaki frekanslarda, odyometride iki grup arasında (FMS grubunda yüksek işitme frekansları) anlamlı bir fark olduğunu gözlendi. TARTIŞMA ve SONUÇ: FMS hastalarında, koklea yüksek frekanslarda daha fazla etkilenebilir ve bu hastalarda koklear, tüy hücresi disfonksiyonuna neden olabilir.

PDF

___

1. Bjørklund G, Dadar M, Chirumbolo S, Aaseth J. Fibromyalgia and nutrition: Therapeutic possibilities? Biomed Pharmacother. 2018 Apr 17;103:531-8.

2. doi:10.1016/j.biopha.2018.04.056. [Epub ahead of print]

3. Watson NF, Buchwald D, Goldberg J, Noonan C, Ellenbogen RG. Neurologic signs and symptoms in fibromyalgia.Arthritis Rheum. 2009.Sep;60(9):2839-44. doi: 10.1002/art.24772.

4. Talotta R, Bazzichi L, Di Franco M, Casale R, Batticciotto A, Gerardi MC, Sarzi-Puttini P. One year in review 2017: fibromyalgia. Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):6-12. Epub 2017 Jun 28.

5. Bayazit YA, Gürsoy S, Ozer E, Karakurum G, Madenci E. Neurotologic manifestations of the fibromyalgia syndrome.J Neurol Sci. 2002 Apr 15;196(1-2):77-80.

6. Rosenhall U, Johansson G, Orndahl G.Otoneurologic and audiologic findings in fibromyalgia.Scand J Rehabil Med. 1996Dec;28(4):225-32.

7. Sawada F, Nomura Y, Goto F, Murakami M, Jike M, Toi T, et al. Relationship of physical distress to dizziness in patients with fibromyalgia.Acta Otolaryngol. 2016;136(1):56-61. doi: 10.3109/00016489.2015.1088662. Epub 2015 Oct 8.

8. Wooles N, Mulheran M, Bray P, Brewster M, Banerjee AR. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure. J Laryngol Otol. 2015 Dec;129(12):1174-81. doi: 10.1017/S0022215115002790. Epub 2015 Nov 9.

9. Kitao K, Mutai H, Namba K, Morimoto N, Nakano A, Arimoto Y, et al. Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds. Ear Hear. 2018Apr23.doi:10.1097/AUD.0000000000000586. [Epub ahead of print]

10. Carvallo RM, Sanches SG, Ibidi SM, Soares JC, Durante AS. Efferent inhibition of otoacoustic emissions in preterm neonates. Braz J Otorhinolaryngol. 2015 Sep-Oct;81(5):491-7. doi: 10.1016/j.bjorl.2015.07.008. Epub 2015 Jul 22.

11. McFadden D, Pasanen EG, Maloney MM, Leshikar EM, Pho MH. Correlations between otoacoustic emissions and performance in common psychoacoustical tasks. J Acoust Soc Am. 2018 Apr;143(4):2355.

12. Hoth S, Balji? I. Current audiological diagnostics. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017 Dec 18;16:Doc09. doi: 10.3205/cto000148. eCollection 2017.

13. Singh PP, Gupta N, Verma P. Transient Evoked and Distortion Product Otoacoustic Emission Profile in Patients of Otosclerosis: A Preliminary Report.Indian J Otolaryngol Head Neck Surg. 2012 Mar; 64(1): 25–30. Published online 2011 Feb 23. doi: 10.1007/s12070-011-0148-3

14. Tilanus SC, Stenis DV, Snik AFM. Otoacoustic emission measurements in evaluation of the immediate effect of ventilation tube insertion in children. Ann Otol Rhinol Laryngol. 1995;104:297– 300. [PubMed]

15. Shea JJ. Thirty years of stapes surgery. J Laryngol Otol. 1988;102:14–19.

16. Plinkert PK, Bootz F, Vojieck T. Influence of static middle ear pressure on transiently evoked otoacoustic emissions and distortion products. Eur Arch Otorhinolaryngol. 1994;251(2):95–99.

17. Emadi M, Rezaei M, Najafi S, Faramarzi A, Farahani F. Comparison of the Transient Evoked Otoacoustic Emissions (TEOAEs) and Distortion Products Otoacoustic Emissions (DPOAEs) in Normal Hearing Subjects With and Without Tinnitus. Indian J Otolaryngol Head Neck Surg. 2018 Mar;70(1):115-118. doi: 10.1007/s12070-015- 0824-9. Epub 2015 Jan 20.

18. Nadon V, Bockstael A, Botteldooren D, Voix J. Field Monitoring of Otoacoustic Emissions During Noise Exposure: Pilot Study in Controlled Environment. Am J Audiol. 2017 Oct 12;26(3S):352-368. doi: 10.1044/2017_AJA-17- 0003.

19. Littlejohn G, Guymer E. Neurogenic inflammation in fibromyalgia. Semin Immunopathol. 2018 Mar 19. doi: 10.1007/s00281- 018-0672-2. [Epub ahead of print]

20. Gunduz B, Bayazit YA, Celenk F, Sarido?an C, Guclu AG, Orcan E, Meray J. Absence of contralateral suppression of transiently evoked otoacoustic emissions in fibromyalgia syndrome. J Laryngol Otol. 2008 Oct;122(10):1047-51. Epub 2008 Mar 4.

21. Yilmaz M, Baysal E, Gunduz B, Aksu A, Ensari N, Meray J, Bayazit YA. Assessment of the ear and otoacoustic emission findings in fibromyalgia syndrome. Clin Exp Rheumatol. 2005 Sep- Oct;23(5):701-3.